Results 181 to 190 of about 147,278 (254)

Outcome of treatment with trametinib in adults with histiocytic neoplasms in the United Kingdom

British Journal of Haematology, EarlyView.
Trametinib (MEK inhibitor) shows efficacy in refractory and high‐risk adult histiocytic neoplasms. At a median follow‐up of 21.4 months, the clinical response rate was 81% (30/37) and the radiological response was 68% (25/37) (n = 37).
Rodothea Amerikanou, Talha Munir, Kristian Bowles, Christopher McNamara, Nikesh Chavda, Elizabeth Price, Jagdish Adiyodi, Alasdair Coles, Philippa Kelsey, Jeffery Smith, Richard Adams, Hayder Hussein, Rui Zhao, Trung Nguyen, Matthew Collin, Satyen Gohil   +15 more
wiley   +1 more source

Paraneoplastic Pulmonary Embolism Revealing Metastatic Uterine Carcinosarcoma. [PDF]

Case Rep Oncol Med
Tayar E, Bitar A, Ibrahim M.
europepmc   +1 more source

PULMONARY EMBOLISM

Annals of Surgery, 1940
openaire   +3 more sources

Hydroxyurea (hydroxycarbamide) use in adults with haemoglobin SC disease: A real‐world study in Quebec

British Journal of Haematology, EarlyView.
Summary Haemoglobin SC (HbSC) disease is the second most prevalent form of sickle cell disease, but evidence for hydroxyurea (hydroxycarbamide; HU) to prevent pain episodes was limited until the prospective identification of variables as outcomes for treatment (PIVOT) trial.
Alice Girard, Laurianne Charette, Mélissa Haouchine, Laurence Bozec, Mohamed Zakaria Bachir Bouyadjera, Mariane Poitras, Vincent‐Thierry Taillefer, Chloé Trudeau, Yves Pastore, Nathalie Letarte, Stéphanie Forté   +10 more
wiley   +1 more source

Treatment of acute pulmonary embolism: anticoagulation, fibrinolysis, and thrombectomy compared. [PDF]

Eur Heart J Suppl
Manzi G, Badagliacca R, Papa S, Vizza CD.   +3 more
europepmc   +1 more source

Evaluating high‐sensitivity troponin levels in people with sickle cell disease in the emergency department

British Journal of Haematology, EarlyView.
This study shows that sickle cell disease patients have elevated high‐sensitivity cardiac troponin I (hs‐cTnI) that is not considered clinically significant but are outside of the normal range. Elevated hs‐cTnI was associated with low haemoglobin and a history of heart failure.
Abdelrhman Mohammed, Najibah A. Galadanci, Gerhard Hellemann, Julie Kanter   +3 more
wiley   +1 more source

Myval, Pulmonary and Cardiac Rehabilitation, Pulmonary Embolism…. [PDF]

Anatol J Cardiol
Erol Ç.
europepmc   +1 more source

The DNA/RNA autophagy protein SIDT2 as a novel neuropathological hallmark in Huntington disease

Brain Pathology, EarlyView.
SIDT2‐immunoreactive inclusions are observed in the striatum, cerebral cortex, and hypothalamus in HD cases with different Vonsattel grades, and the frequency of SIDT2‐immunoreactive inclusions is associated with longer CAG repeats in the huntingtin gene.
Sanaz Gabery, Sofia Bergh, Chrisovalantou Huridou, Rachel Y. Cheong, Barbara Baldo, Paul Günther Scheunemann, Marie‐Louisa Schoebel, Linda Holmquist Mengelbier, Elisabet Englund, Catriona McLean, Carsten Saft, Deniz Kirik, Maria Björkqvist, Glenda Halliday, Elisabeth Petrasch‐Parwez, Huu Phuc Nguyen, Jonasz Jeremiasz Weber, Åsa Petersén   +17 more
wiley   +1 more source

The vulnerable elders Survey-13 scale is superior to the simplified pulmonary embolism score index in predicting post-pulmonary embolism dyspnea in elderly survivors of acute pulmonary embolism. [PDF]

BMC Geriatr
Imiela AM, Kozak-Szkopek E, Kurnicka K, Dzikowska-Diduch O, Żuk-Łapan A, Niewczas K, Wasilewski O, Pruszczyk P.   +7 more
europepmc   +1 more source